Home Cart 0 Sign in  

[ CAS No. 651744-48-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 651744-48-8
Chemical Structure| 651744-48-8
Structure of 651744-48-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 651744-48-8 ]

Related Doc. of [ 651744-48-8 ]

Alternatived Products of [ 651744-48-8 ]

Product Details of [ 651744-48-8 ]

CAS No. :651744-48-8 MDL No. :MFCD09763673
Formula : C16H25ClN2Si Boiling Point : -
Linear Structure Formula :- InChI Key :HSMLARVFJADZQS-UHFFFAOYSA-N
M.W : 308.92 Pubchem ID :11438272
Synonyms :

Safety of [ 651744-48-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 651744-48-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 651744-48-8 ]
  • Downstream synthetic route of [ 651744-48-8 ]

[ 651744-48-8 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 651744-48-8 ]
  • [ 98549-88-3 ]
Reference: [1] Tetrahedron Letters, 2004, vol. 45, # 11, p. 2317 - 2319
  • 2
  • [ 541-41-3 ]
  • [ 651744-48-8 ]
  • [ 885500-55-0 ]
YieldReaction ConditionsOperation in experiment
88%
Stage #1: With sec.-butyllithium In tetrahydrofuran; hexane; cyclohexane at -78℃; for 1 h; Inert atmosphere
Stage #2: at -78℃; for 0.5 h; Inert atmosphere
Stage #3: With tetrabutyl ammonium fluoride In tetrahydrofuran; hexane; cyclohexane at 20℃; for 1 h; Inert atmosphere
To a solution of 7 (15 g, 48.6 mmol) in tetrahydrofuran (THF) (150 mL), 1 M sec-BuLi in cyclohexane and n-hexane (97.1 mL, 97.1 mmol) was added dropwise at −78°C under Ar gas atmosphere. The mixture was stirred at the same temperature for 1 h, and then ethyl chloroformate (9.29 mL,97.1 mmol) was added at −78°C. After stirring at the same temperature for additional 30 min, the mixture was quenched with saturated NH4Cl aqueous solution and extracted with EtOAc. The extract was washed with H2O and brine, dried over MgSO4, and concentrated under reduced pressure. The residue was dissolved in THF (120 mL), and 1 M TBAF in THF (56 mL, 56 mmol) was added. The mixture was stirred at room temperature for 1 h and then diluted with EtOAc, washed with H2O, dried over MgSO4, and concentrated under reduced pressure. The residue was triturated with IPE, and the precipitate was filtrated to give the title compound (9.6 g, 88percent). 1H-NMR (DMSO-d6) δ: 1.36 (3H, t, J=7.1 Hz), 4.36 (2H, q, J=7.1 Hz), 6.64–6.67 (1H, m), 7.70–7.73 (1H, m), 8.71 (1H, s), 12.41 (1H,br). MS (ESI) m/z: 223 (M−H).
Reference: [1] Chemical and Pharmaceutical Bulletin, 2015, vol. 63, # 5, p. 341 - 353
  • 3
  • [ 651744-48-8 ]
  • [ 885500-55-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 3, p. 693 - 698
  • 4
  • [ 651744-48-8 ]
  • [ 920966-03-6 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2015, vol. 63, # 5, p. 341 - 353
  • 5
  • [ 651744-48-8 ]
  • [ 876343-82-7 ]
Reference: [1] ChemMedChem, 2014, vol. 9, # 2, p. 277 - 281
[2] Patent: WO2018/191587, 2018, A1,
  • 6
  • [ 651744-48-8 ]
  • [ 1015610-31-7 ]
YieldReaction ConditionsOperation in experiment
73%
Stage #1: With sec.-butyllithium In tetrahydrofuran; cyclohexane at -78℃; for 0.5 h;
Stage #2: With iodine In tetrahydrofuran; cyclohexane at -78℃; for 0.333333 h;
Stage #3: With tetrabutyl ammonium fluoride In tetrahydrofuran at 20℃; for 0.166667 h;
[00334] Step B: S-BuLi (59.3 mL, 71.2 mmol, 1.4M in cyclohexane) at -78°C was added to 4-chloro-l-(triisopropylsilyl)-lH-pyrrolo[2,3-b]pyridine (10.0 g, 32.4 mmol) in THF (100 mL), and the reaction was stirred at -78°C for 30 minutes. L (20.5 g, 80.9 mmol) in THF (50 mL) was added, and the reaction was stirred at -78°C for 20 minutes. A saturated ammonium chloride solution (50 mL) and a saturated sodium sulfite solution (50 mL) were added, and the mixture was extracted with hexanes (200 mL), washed with brine and dried over sodium sulfate. After removal of the solvent, the residue was dissolved in THF (50 mL), and TBAF (32.4 mL, 32.4 mmol) was added. The reaction was stirred at room temperature for 10 minutes, and then water (20 mL) and ethyl acetate (100 mL) were added. The organic layer was separated, washed with brine, and dried over sodium sulfate. After removal of the solvent, the residue was suspended in dichloromethane ("DCM"; 20 mL) and stirred for 10 minutes. The solid formed was collected by filtration to give 4-chloro-5-iodo-lH-pyrrolo[2,3-b]pyridine (6.6 g, 73percent yield) as a solid.
Reference: [1] Patent: WO2009/140320, 2009, A1, . Location in patent: Page/Page column 98
[2] Journal of Medicinal Chemistry, 2013, vol. 56, # 3, p. 1160 - 1170
[3] Patent: WO2013/114113, 2013, A1,
[4] Patent: US2015/11533, 2015, A1,
[5] Patent: US2015/218155, 2015, A1,
  • 7
  • [ 651744-48-8 ]
  • [ 951625-93-7 ]
Reference: [1] Patent: WO2012/58645, 2012, A1,
[2] Patent: WO2016/123392, 2016, A2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 651744-48-8 ]

Organosilicon

Chemical Structure| 1093759-49-9

[ 1093759-49-9 ]

1-[Tris(1-methylethyl)silyl]-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.87